EUVIMEDEUVIMED entdecken
Open Access

Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia

Xiao-Lin Zhong, Yan Huang, Yang Du, Li-Zheng He, Yue-Wen Chen, Yong Cheng iD, Hua Liu

Schizophrenia Bulletin · 2024

DOI: 10.1093/schbul/sbad172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2024. Verfasst von Xiao-Lin Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China. Hauptthemen laut MEDLINE: Schizophrenia, Exosomes, Olfactory Mucosa, Neurogenesis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Schizophrenia (SCZ) is a multifaceted mental disorder marked by a spectrum of symptoms, including hallucinations, delusions, cognitive deficits, and negative symptoms. Its etiology involves intricate interactions between genetic and environmental factors, posing significant challenges for effective treatment. We hypothesized that intranasal administration of exosomes derived from nasal olfactory mucosal mesenchymal stem cells (OM-MSCs-exos) could alleviate SCZ-like behaviors in a murine model induced by methylazoxymethanol (MAM). Study Design We conducted a comprehensive investigation to assess the impact of intranasally delivered OM-MSC-exos on SCZ-like behaviors in MAM-induced mice. This study encompassed behavioral assessments, neuroinflammatory markers, glial activation, synaptic protein expression, and neurogenesis within the hippocampus. Study Results Our findings demonstrated that intranasal administration of OM-MSC-exos effectively ameliorated SCZ-like behaviors, specifically addressing social withdrawal and sensory gating deficits in the MAM-induced murine model. Furthermore, OM-MSC-exos intervention yielded a reduction in neuroinflammatory markers and a suppression of microglial activation within the hippocampus. Simultaneously, we observed an upregulation of key synaptic protein expression, including PSD95 and TH, the rate-limiting enzyme for dopamine biosynthesis. Conclusions Our study underscores the therapeutic potential of OM-MSC-exos in mitigating SCZ-like behavior. The OM-MSC-exos have the capacity to modulate glial cell activation, diminish neuroinflammation, and promote BDNF-associated synaptic plasticity and neurogenesis, thus ameliorating SCZ-like behaviors. In summary, intranasal administration of OM-MSC-exos offers a multifaceted approach to address SCZ mechanisms, promising innovative treatments for this intricate disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaExosomesOlfactory MucosaNeurogenesisNeuronal PlasticityNeuroinflammatory DiseasesMesenchymal Stem CellsDisease Models, AnimalAdministration, IntranasalAnimalsMiceMaleHippocampusMethylazoxymethanol AcetateBehavior, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

exosomeneurogenesisneuroinflammationschizophreniasynaptic plasticity

Substanzen

Methylazoxymethanol Acetate

Autor:innen und Institutionen

  • Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • NHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospital), Changsha, Hunan 410008, China.
  • First Clinical Department, Changsha Medical University, Changsha, Hunan 410219, P.R.China.
  • Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, China.
  • Chinese Academy of Sciences Key Laboratory of Brain Connectome and Manipulation, Shenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute…
  • Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen 518055, China.

ORCID-Profile: Yong Cheng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Zhong, X. L., Huang, Y., Du, Y., He, L. Z., Chen, Y. W., Cheng, Y., & Liu, H. (2024). Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbad172

Vancouver

Zhong XL, Huang Y, Du Y, He LZ, Chen YW, Cheng Y, et al. Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbad172

BibTeX
@article{Zhong2024,
  author = {Zhong, Xiao-Lin and Huang, Yan and Du, Yang and He, Li-Zheng and Chen, Yue-Wen and Cheng, Yong and Liu, Hua},
  title = {Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia},
  journal = {Schizophrenia Bulletin},
  year = {2024},
  doi = {10.1093/schbul/sbad172}
}
Kostenlos starten →